Lohse, Ansgar W.

Simplified criteria for the diagnosis of autoimmune hepatitis

Hennes, E. M., Zeniya, M., Czaja, A. J., Parés, A., Dalekos, G. N., Krawitt, E. L., Bittencourt, P. L., Porta, G., Boberg, K. M., Hofer, H., et al. (2008) · Hepatology

Liver Diseases and ImmunityIgG4-Related and Inflammatory Diseases

Cited by 1,901

Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue

Boberg, K. M., Chapman, R. W., Hirschfield, G. M., Lohse, A. W., Manns, M. P., & Schrumpf, E. (2011) · Journal of Hepatology

Liver Diseases and ImmunityIgG4-Related and Inflammatory Diseases

Cited by 555

Immune tolerance: What is unique about the liver

Tiegs, G., & Lohse, A. W. (2010) · Journal of Autoimmunity

T-cell and B-cell ImmunologyLiver Diseases and Immunity

Cited by 394

Genome-Wide Association Study Identifies Variants Associated With Autoimmune Hepatitis Type 1

de Boer, Y. S., van Gerven, N. M. F., Zwiers, A., Verwer, B. J., van Hoek, B., van Erpecum, K. J., Beuers, U., van Buuren, H. R., Drenth, J. P. H., den Ouden, J. W., et al. (2014) · Gastroenterology

Liver Diseases and ImmunityGenetic Associations and Epidemiology

Cited by 304

Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals

Lohse, A. W., zum Büschenfelde, K.-H. M., Franz, B., Kanzler, S., Gerken, G., & Dienes, H.-P. (1999) · Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 278

TGF-β-dependent induction of CD4+CD25+Foxp3+ Tregs by liver sinusoidal endothelial cells

Carambia, A., Freund, B., Schwinge, D., Heine, M., Laschtowitz, A., Huber, S., Wraith, D. C., Korn, T., Schramm, C., Lohse, A. W., et al. (2014) · Journal of Hepatology

T-cell and B-cell ImmunologyTGF-β signaling in diseases

Cited by 241

Mhc Class Ii–Expressing Hepatocytes Function As Antigen–Presenting Cells and Activate Specific Cd4 T Lymphocyutes

Herkel, J., Jagemann, B., Wiegard, C., Lazaro, J. F. G., Lueth, S., Kanzler, S., Blessing, M., Schmitt, E., & Lohse, A. W. (2003) · Hepatology

Liver Diseases and ImmunityImmunotherapy and Immune Responses

Cited by 164

Alterations of the bile microbiome in primary sclerosing cholangitis

Liwinski, T., Zenouzi, R., John, C., Ehlken, H., Rühlemann, M. C., Bang, C., Groth, S., Lieb, W., Kantowski, M., Andersen, N., et al. (2020) · Gut

Liver Diseases and ImmunityGut microbiota and health

Cited by 149

Health-related quality of life, depression, and anxiety in patients with autoimmune hepatitis

Schramm, C., Wahl, I., Weiler-Normann, C., Voigt, K., Wiegard, C., Glaubke, C., Brähler, E., Löwe, B., Lohse, A. W., & Rose, M. (2014) · Journal of Hepatology

Liver Diseases and ImmunityHealth and Well-being Studies

Cited by 128

Persistent somatic symptoms across diseases - from risk factors to modification: scientific framework and overarching protocol of the interdisciplinary SOMACROSS research unit (RU 5211)

Löwe, B., Andresen, V., Van den Bergh, O., Huber, T. B., von dem Knesebeck, O., Lohse, A. W., Nestoriuc, Y., Schneider, G., Schneider, S. W., Schramm, C., et al. (2022) · BMJ Open

Psychosomatic Disorders and Their TreatmentsMusculoskeletal pain and rehabilitation

Cited by 121

Murine Liver Antigen Presenting Cells Control Suppressor Activity of CD4+CD25+ Regulatory T Cells *

Wiegard, C., Frenzel, C., Herkel, J., Kallen, K.-J., Schmitt, E., & Lohse, A. W. (2005) · Hepatology

T-cell and B-cell ImmunologyLiver physiology and pathology

Cited by 97

Apoptotic cell identity induces distinct functional responses to IL-4 in efferocytic macrophages

Liebold, I., Al Jawazneh, A., Casar, C., Lanzloth, C., Leyk, S., Hamley, M., Wong, M. N., Kylies, D., Gräfe, S. K., Edenhofer, I., et al. (2024) · Science

Phagocytosis and Immune RegulationImmune cells in cancer

Cited by 96

Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain?

Corpechot, C., Lemoinne, S., Soret, P.-A., Hansen, B., Hirschfield, G., Gulamhusein, A., Montano-Loza, A. J., Lytvyak, E., Pares, A., Olivas, I., et al. (2024) · Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 94

Monocytes as Potential Mediators of Pathogen‐Induced T‐Helper 17 Differentiation in Patients With Primary Sclerosing Cholangitis (PSC)

Kunzmann, L. K., Schoknecht, T., Poch, T., Henze, L., Stein, S., Kriz, M., Grewe, I., Preti, M., Hartl, J., Pannicke, N., et al. (2020) · Hepatology

Liver Diseases and ImmunityInflammatory Bowel Disease

Cited by 93

Low risk of hepatocellular carcinoma in patients with primary sclerosing cholangitis with cirrhosis

Zenouzi, R., Weismüller, T. J., Hübener, P., Schulze, K., Bubenheim, M., Pannicke, N., Weiler–Normann, C., Lenzen, H., Manns, M. P., Lohse, A. W., et al. (2014) · Clinical Gastroenterology and Hepatology

Liver Diseases and ImmunityHepatocellular Carcinoma Treatment and Prognosis

Cited by 86

Pregnancy in primary sclerosing cholangitis

Wellge, B. E., Sterneck, M., Teufel, A., Rust, C., Franke, A., Schreiber, S., Berg, T., Günther, R., Kreisel, W., zu Eulenburg, C., et al. (2011) · Gut

Liver Diseases and ImmunityPregnancy and Medication Impact

Cited by 76

Unmet clinical need in autoimmune liver diseases

Dyson, J. K., Webb, G., Hirschfield, G. M., Lohse, A., Beuers, U., Lindor, K., & Jones, D. E. J. (2015) · Journal of Hepatology

Liver Diseases and ImmunityIgG4-Related and Inflammatory Diseases

Cited by 66

Therapeutic Targeting of Myeloperoxidase Attenuates NASH in Mice

Koop, A. C., Thiele, N. D., Steins, D., Michaëlsson, E., Wehmeyer, M., Scheja, L., Steglich, B., Huber, S., Schulze zur Wiesch, J., Lohse, A. W., et al. (2020) · Hepatology Communications

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 48

The development of irritable bowel syndrome: a prospective community-based cohort study

Löwe, B., Lohse, A., Andresen, V., Vettorazzi, E., Rose, M., & Broicher, W. (2016) · American Journal of Gastroenterology

Gastrointestinal motility and disordersPsychosomatic Disorders and Their Treatments

Cited by 43

Th17 cell frequency is associated with low bone mass in primary sclerosing cholangitis

Schmidt, T., Schwinge, D., Rolvien, T., Jeschke, A., Schmidt, C., Neven, M., Butscheidt, S., Kriz, M., Kunzmann, L., Mussawy, H., et al. (2019) · Journal of Hepatology

Liver Diseases and ImmunityBone health and osteoporosis research

Cited by 42

Nachweis von SLA/LP-Autoantikörpern bei Patienten mit primär biliärer Zirrhose als Marker für eine sekundäre autoimmune Hepatitis (Overlapsyndrom)

Kanzler, S., Bozkurt, S., Herkel, J., Galle, P., Dienes, H., & Lohse, A. (2001) · DMW - Deutsche Medizinische Wochenschrift

Liver Diseases and ImmunityIgG4-Related and Inflammatory Diseases

Cited by 33

Nanoparticle‐mediated targeting of autoantigen peptide to cross‐presenting liver sinusoidal endothelial cells protects from CD8 T‐cell‐driven autoimmune cholangitis

Carambia, A., Gottwick, C., Schwinge, D., Stein, S., Digigow, R., Şeleci, M., Mungalpara, D., Heine, M., Schuran, F. A., Corban, C., et al. (2021) · Immunology

Liver Diseases and ImmunityImmunotherapy and Immune Responses

Cited by 30

Multicytokine-producing CD4+ T cells characterize the livers of patients with NASH

Woestemeier, A., Scognamiglio, P., Zhao, Y., Wagner, J., Muscate, F., Casar, C., Siracusa, F., Cortesi, F., Agalioti, T., Müller, S., et al. (2023) · JCI Insight

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 28

Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis

Peiseler, M., Reiners, D., Pinnschmidt, H. O., Sebode, M., Jung, F., Hartl, J., Zenouzi, R., Ehlken, H., Groth, S., Schachschal, G., et al. (2018) · PLOS ONE

Liver Diseases and ImmunityGallbladder and Bile Duct Disorders

Cited by 17